Sule Temizkan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sule Temizkan has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Aysenur Ozderya
B Department of Endocrinology and Metabolism , University of Medical Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital , Istanbul , Turkey
10 shared publicationsKadriye Aydin
B Department of Endocrinology and Metabolism , University of Medical Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital , Istanbul , Turkey
7 shared publications- Kadriye Aydin
Kartal Lutfi Kirdar Research and Training Hospital
6 shared publications Aylin Ege Gul
Department of Pathology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, 34890, Istanbul, Turkey
4 shared publicationsMehmet Sargin
Department of Family Medicine, Medeniyet University Goztepe Training and Research Hospital, 34722 Istanbul, Turkey
4 shared publicationsSule Ozugur
Department of Nuclear Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, 34890, Istanbul, Turkey
4 shared publications
Latest Publications
- Open Access
- 15 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20435
New Anthropometric Measurements: Relationship to Thyroid Functions in Euthyroid Obese Subjects
Body mass index (BMI) is unable to make a distinction between muscle mass and fat mass. Therefore, new anthropometric measurements, such as a body shape index (ABSI), body round index (BRI), and body adiposity index (BAI), have been formulated in recent years. Many studies have reported a correlation between BMI and thyroid function. In this study, we aimed to investigate the relationship between the above-mentioned new anthropometric measurements and thyroid functions in euthyroid obese subjects. We included 675 euthyroid (TSH ≥ 0.4 and < 4.5 mIU/l) individuals from the obesity outpatient clinic, aged between 18 and 65 years old, with BMI ≥ 30. Thyroid-stimulating hormone (TSH), free T4 (fT4) and free T3 (fT3), anthropometric measurements (weight, height, and waist circumference), and bioelectric impedance analyses [percent body fat (PBF) and fat-free mass (FFM)] of individuals were measured and recorded. ABSI, BRI, and BAI were calculated with the data from these measurements. Anthropometric measurements were compared to thyroid function tests. Eighty percent of the subjects were female. The mean age and BMI were 38 ± 17 years and 38 ± 6 kg/m2, respectively. TSH was found to be negatively correlated with ABSI (p = 0.006) and positively correlated with BAI (p < 0.001), but a statistically significant relationship with BRI (p = 0.193) was not determined. Free T4 was not associated with any of the anthropometric measurements. While fT3 was determined to be positively correlated with ABSI (p = 0.008) and negatively correlated with PBF and BAI (p = 0.001, p = 0.002, respectively), no statistically significant relationship with fT3 and BRI was determined. TSH is positively correlated with measurements of adiposity such as BMI, PBF, BAI while indexes in which abdominal obesity increases, such as waist circumference (WC), waist-hip ratio (WHR), and ABSI, are correlated with fT3 levels.
- 15 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20435
Open AccessNew Anthropometric Measurements: Relationship to Thyroid Functions in Euthyroid Obese Subjects
Body mass index (BMI) is unable to make a distinction between muscle mass and fat mass. Therefore, new anthropometric measurements, such as a body shape index (ABSI), body round index (BRI), and body adiposity index (BAI), have been formulated in recent years. Many studies have reported a correlation between BMI and thyroid function. In this study, we aimed to investigate the relationship between the above-mentioned new anthropometric measurements and thyroid functions in euthyroid obese subjects. We included 675 euthyroid (TSH ≥ 0.4 and < 4.5 mIU/l) individuals from the obesity outpatient clinic, aged between 18 and 65 years old, with BMI ≥ 30. Thyroid-stimulating hormone (TSH), free T4 (fT4) and free T3 (fT3), anthropometric measurements (weight, height, and waist circumference), and bioelectric impedance analyses [percent body fat (PBF) and fat-free mass (FFM)] of individuals were measured and recorded. ABSI, BRI, and BAI were calculated with the data from these measurements. Anthropometric measurements were compared to thyroid function tests. Eighty percent of the subjects were female. The mean age and BMI were 38 ± 17 years and 38 ± 6 kg/m2, respectively. TSH was found to be negatively correlated with ABSI (p = 0.006) and positively correlated with BAI (p < 0.001), but a statistically significant relationship with BRI (p = 0.193) was not determined. Free T4 was not associated with any of the anthropometric measurements. While fT3 was determined to be positively correlated with ABSI (p = 0.008) and negatively correlated with PBF and BAI (p = 0.001, p = 0.002, respectively), no statistically significant relationship with fT3 and BRI was determined. TSH is positively correlated with measurements of adiposity such as BMI, PBF, BAI while indexes in which abdominal obesity increases, such as waist circumference (WC), waist-hip ratio (WHR), and ABSI, are correlated with fT3 levels.
- 1 December 2021
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 35 (12) , 108073
Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients
- 1 December 2021
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 35 (12) , 108073
Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients
- Open Access
- 15 August 2021
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 1 (2) , 27-34
Relationship between microalbuminuria and metabolic parameters in a normotensive population with obesity
Aim: Today, the second-most common cause of preventable death after smoking is obesity. Microalbuminuria is defined as an albumin to creatinine ratio (ACR) of more than 30 mg per gram of creatinine. Obesity increases microalbuminuria by affecting the kidneys.Methods: This study was carried out by retrospectively examining the files of obese [Body mass index (BMI) ≥30 kg/m2)] individuals between the ages of 18 and 65 with spot microalbuminuria test in urine who admitted to the obesity outpatient clinic of a tertiary hospital between January 2013 and June 2015. Four hundred ninety subjects were included in the study. The physical parameters, blood and urine tests of the subjects included in the study at the time of first admission to the obesity clinic were examined.Results: Microalbuminuria was positive in 5.7 % of the participants. The glycated hemoglobin (HbA1c) and uric acid levels for subjects in the microalbuminuria-positive group were higher than in the levels of subjects in the microalbuminuria-negative group [5.6 (5.8-5.5) vs 5.5 (5.7-5.2); P=0.012 and 5.2 (6-4.5) vs 4.7 (5.5-4.2); P=0.038, respectively]. In microalbuminuria-negative group, 25-hydroxyvitamin D3 (25-OH D3) levels were higher than in the microalbuminuria-positive group [12 (18-7.1) vs 8.4 (12.9-6.9); P=0.032]. Urine albumin to creatinine ratio was positively associated with BMI, fasting insulin (FI), Homeostatic model assessment for insulin resistance (HOMA-IR), triglycerides (TG) and c-reactive protein (CRP).Conclusion: Obesity increases microalbuminuria by affecting the kidneys. Microalbuminuria is associated with insulin resistance, dyslipidemia and low 25-OH D3. Microalbuminuria must be checked in obese individuals. The prevalence of obesity should be reduced for a healthier life.
- 15 August 2021
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 1 (2) , 27-34
Open AccessRelationship between microalbuminuria and metabolic parameters in a normotensive population with obesity
Aim: Today, the second-most common cause of preventable death after smoking is obesity. Microalbuminuria is defined as an albumin to creatinine ratio (ACR) of more than 30 mg per gram of creatinine. Obesity increases microalbuminuria by affecting the kidneys.Methods: This study was carried out by retrospectively examining the files of obese [Body mass index (BMI) ≥30 kg/m2)] individuals between the ages of 18 and 65 with spot microalbuminuria test in urine who admitted to the obesity outpatient clinic of a tertiary hospital between January 2013 and June 2015. Four hundred ninety subjects were included in the study. The physical parameters, blood and urine tests of the subjects included in the study at the time of first admission to the obesity clinic were examined.Results: Microalbuminuria was positive in 5.7 % of the participants. The glycated hemoglobin (HbA1c) and uric acid levels for subjects in the microalbuminuria-positive group were higher than in the levels of subjects in the microalbuminuria-negative group [5.6 (5.8-5.5) vs 5.5 (5.7-5.2); P=0.012 and 5.2 (6-4.5) vs 4.7 (5.5-4.2); P=0.038, respectively]. In microalbuminuria-negative group, 25-hydroxyvitamin D3 (25-OH D3) levels were higher than in the microalbuminuria-positive group [12 (18-7.1) vs 8.4 (12.9-6.9); P=0.032]. Urine albumin to creatinine ratio was positively associated with BMI, fasting insulin (FI), Homeostatic model assessment for insulin resistance (HOMA-IR), triglycerides (TG) and c-reactive protein (CRP).Conclusion: Obesity increases microalbuminuria by affecting the kidneys. Microalbuminuria is associated with insulin resistance, dyslipidemia and low 25-OH D3. Microalbuminuria must be checked in obese individuals. The prevalence of obesity should be reduced for a healthier life.
- 7 February 2019
- Published by Springer Nature in Pituitary
- Vol. 22 (3) , 220-228
A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction
This review aimed to evaluate the data underlying the pathophysiology of TBI-induced hypothalamo-pituitary dysfunction.
- 7 February 2019
- Published by Springer Nature in Pituitary
- Vol. 22 (3) , 220-228
A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction
This review aimed to evaluate the data underlying the pathophysiology of TBI-induced hypothalamo-pituitary dysfunction.
- 24 January 2019
- Published by Wiley in World Journal of Surgery
- Vol. 43 (5) , 1243-1248
Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study
Background: To investigate the relationship between primary hyperparathyroidism (pHPT) and papillary thyroid cancer (PTC).Methods: The perioperative findings of 275 patients with pHPT who underwent surgery between January 2014 and December 2017 were retrospectively reviewed. Thirty‐one patients were diagnosed with pHPT and PTC concurrently. Pathology results and demographic findings of these patients were compared with 186 patients who underwent thyroidectomy and diagnosed with PTC at the same time interval.Results: The co‐occurrence of pHPT and PTC was 11.3% (31/275). The median ages of the pHPT, pHPT + PTC, and PTC groups were 55, 57, and 50 years old, respectively (p < 0.001). The diameter of tumor was smaller in the pHPT + PTC group [median 7 mm (range 0.5–25 mm) vs. 15 mm (range 1–100 mm)], with higher rates of microcarcinomas (p < 0.001), than the patients in the PTC group. Examination of tumor morphology showed higher rates of tumor capsule invasion and multicentricity in the pHPT + PTC group than those in the isolated PTC group (p = 0.02, p = 0.04, respectively).Conclusion: The pHPT + PTC group had significantly smaller tumor diameter than the PTC group. This result may support the idea that pHPT leads to overdiagnosis of PTC. However, observation of high rates of tumor capsule invasion and multicentricity in the pHPT + PTC group may suggest an associative etiology with more aggressive PTC.
- 24 January 2019
- Published by Wiley in World Journal of Surgery
- Vol. 43 (5) , 1243-1248
Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study
Background: To investigate the relationship between primary hyperparathyroidism (pHPT) and papillary thyroid cancer (PTC).Methods: The perioperative findings of 275 patients with pHPT who underwent surgery between January 2014 and December 2017 were retrospectively reviewed. Thirty‐one patients were diagnosed with pHPT and PTC concurrently. Pathology results and demographic findings of these patients were compared with 186 patients who underwent thyroidectomy and diagnosed with PTC at the same time interval.Results: The co‐occurrence of pHPT and PTC was 11.3% (31/275). The median ages of the pHPT, pHPT + PTC, and PTC groups were 55, 57, and 50 years old, respectively (p < 0.001). The diameter of tumor was smaller in the pHPT + PTC group [median 7 mm (range 0.5–25 mm) vs. 15 mm (range 1–100 mm)], with higher rates of microcarcinomas (p < 0.001), than the patients in the PTC group. Examination of tumor morphology showed higher rates of tumor capsule invasion and multicentricity in the pHPT + PTC group than those in the isolated PTC group (p = 0.02, p = 0.04, respectively).Conclusion: The pHPT + PTC group had significantly smaller tumor diameter than the PTC group. This result may support the idea that pHPT leads to overdiagnosis of PTC. However, observation of high rates of tumor capsule invasion and multicentricity in the pHPT + PTC group may suggest an associative etiology with more aggressive PTC.
- 16 October 2018
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (2) , 128-132
Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome
Potential effect of hyperandrogenemia on metabolic disturbances in polycystic ovary syndrome (PCOS) has always been a matter of interest. We analyzed the records of 125 patients with PCOS and 54 age-matched healthy women. All participants underwent biochemical and hormonal assessment and a 75 g oral glucose tolerance test was performed. PCOS and control groups were comparable in terms of age. Dehydroepiandrosterone sulfate/free androgen index (DHEAS/FAI) ratio was negatively correlated with body mass index (BMI) (p < .001), fasting glucose (p = .02), area under the curve (AUC) of glucose (p = .03), AUC of insulin (p = .001), homeostasis model assessment-estimated insulin resistance (HOMA-IR) (p < .001), and triglycerides (TG) (p = .009), and positively correlated with insulin sensitivity index (ISI) (p < .001) and high-density lipoprotein cholesterol (HDL-C) (p < .001) among PCOS patients. In logistic regression analysis, higher DHEAS/FAI ratio levels were associated with lower risk of low HDL-C [RR(95%CI); 0.97(0.95–0.98); p < .001] as well as atherogenic dyslipidemia (TG/HDL-C) [RR(95%CI); 0.97(0.94–0.99); p = .035] even after adjustment for BMI in the PCOS group. Androgens, DHEAS and FAI act differently on metabolic parameters. Our results demonstrate that high DHEA-S/FAI ratio levels are associated with a more favorable metabolic profile.
- 16 October 2018
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (2) , 128-132
Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome
Potential effect of hyperandrogenemia on metabolic disturbances in polycystic ovary syndrome (PCOS) has always been a matter of interest. We analyzed the records of 125 patients with PCOS and 54 age-matched healthy women. All participants underwent biochemical and hormonal assessment and a 75 g oral glucose tolerance test was performed. PCOS and control groups were comparable in terms of age. Dehydroepiandrosterone sulfate/free androgen index (DHEAS/FAI) ratio was negatively correlated with body mass index (BMI) (p < .001), fasting glucose (p = .02), area under the curve (AUC) of glucose (p = .03), AUC of insulin (p = .001), homeostasis model assessment-estimated insulin resistance (HOMA-IR) (p < .001), and triglycerides (TG) (p = .009), and positively correlated with insulin sensitivity index (ISI) (p < .001) and high-density lipoprotein cholesterol (HDL-C) (p < .001) among PCOS patients. In logistic regression analysis, higher DHEAS/FAI ratio levels were associated with lower risk of low HDL-C [RR(95%CI); 0.97(0.95–0.98); p < .001] as well as atherogenic dyslipidemia (TG/HDL-C) [RR(95%CI); 0.97(0.94–0.99); p = .035] even after adjustment for BMI in the PCOS group. Androgens, DHEAS and FAI act differently on metabolic parameters. Our results demonstrate that high DHEA-S/FAI ratio levels are associated with a more favorable metabolic profile.
- 5 February 2018
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 32 (4) , 250-255
Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism
Technetium 99 m methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy represents the most commonly utilized imaging modality for the detection of the diseased gland in patients with primary hyperparathyroidism (PHPT). In this study, we aimed to identify potential biological factors with an impact on MIBI sensitivity.
- 5 February 2018
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 32 (4) , 250-255
Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism
Technetium 99 m methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy represents the most commonly utilized imaging modality for the detection of the diseased gland in patients with primary hyperparathyroidism (PHPT). In this study, we aimed to identify potential biological factors with an impact on MIBI sensitivity.
- Open Access
- 28 December 2017
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- p. 278-82
Comparison of cortisol responses to low dose ACTH stimuli and injection stress
- 28 December 2017
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- p. 278-82
Open AccessComparison of cortisol responses to low dose ACTH stimuli and injection stress
- 1 September 2017
- Published by Elsevier in Endocrine Practice
- Vol. 23 (9) , 1101-1106
The Results of PArathyroid Hormone Assay in Parathyroid Aspirates in Pre-Operative Localization of Parathyroid Adenomas for Focused Parathyroidectomy in Patients With Negative or Suspicious Technetium-99M-Sestamibi Scans
- 1 September 2017
- Published by Elsevier in Endocrine Practice
- Vol. 23 (9) , 1101-1106
The Results of PArathyroid Hormone Assay in Parathyroid Aspirates in Pre-Operative Localization of Parathyroid Adenomas for Focused Parathyroidectomy in Patients With Negative or Suspicious Technetium-99M-Sestamibi Scans
- 3 May 2017
- Published by Bioscientifica in Endocrine Abstracts
The results of parathormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious sestamibi scans
Objective: In primary hiperparathyroidism (PHPT), increasing the number of patients treated by focused parathyroidectomy should be the main objective of pre-surgical imaging modalities. Suspicious or negative imaging results do not always mean multiglandular disease, most of the patients may single adenoma and therefore these patients may still benefit from focused parathyroidectomy. Methods: Retrospectively, we analyzed the data of 65 patients with PHPT with suspicious or negative sestamibi scans who admitted at a tertiary reference center between January 2013 and December 2016. We excluded patients who had history of chronic renal failure, renal transplant and multiple endocrine neoplasia. All patients underwent an endocrinologist operated ultrasonographic examination and parathyroid fine needle aspiration wash-out procedure. Results: Of the 65 patients, 23 patients had nodular guatr disease. Fifty-four patients had positive parathormone (PTH) wash-out results. A total of 43 patients underwent surgery. Of the 43 patients, four patients had redo-surgery. Of the operated patients, 40 had positive parathormone wash-out results and had successful focused surgery. All of the patients with redo-surgery had positive parathormone wash-out results and successfully re-operated. Three patients with negative PTH wash-out results, two of them had successful bilateral neck exploration, but a patient’s operation was not successful although bilateral neck exploration. Conclusion: Endocrinologist operated US and PTH wash-out increases the number and success of focused surgery. Especially, patients with redo-surgery may benefit from this procedure.
- 3 May 2017
- Published by Bioscientifica in Endocrine Abstracts
The results of parathormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious sestamibi scans
Objective: In primary hiperparathyroidism (PHPT), increasing the number of patients treated by focused parathyroidectomy should be the main objective of pre-surgical imaging modalities. Suspicious or negative imaging results do not always mean multiglandular disease, most of the patients may single adenoma and therefore these patients may still benefit from focused parathyroidectomy. Methods: Retrospectively, we analyzed the data of 65 patients with PHPT with suspicious or negative sestamibi scans who admitted at a tertiary reference center between January 2013 and December 2016. We excluded patients who had history of chronic renal failure, renal transplant and multiple endocrine neoplasia. All patients underwent an endocrinologist operated ultrasonographic examination and parathyroid fine needle aspiration wash-out procedure. Results: Of the 65 patients, 23 patients had nodular guatr disease. Fifty-four patients had positive parathormone (PTH) wash-out results. A total of 43 patients underwent surgery. Of the 43 patients, four patients had redo-surgery. Of the operated patients, 40 had positive parathormone wash-out results and had successful focused surgery. All of the patients with redo-surgery had positive parathormone wash-out results and successfully re-operated. Three patients with negative PTH wash-out results, two of them had successful bilateral neck exploration, but a patient’s operation was not successful although bilateral neck exploration. Conclusion: Endocrinologist operated US and PTH wash-out increases the number and success of focused surgery. Especially, patients with redo-surgery may benefit from this procedure.